Lymphomas after tumor necrosis factor antagonist therapy: comment on the article by Brown et al.
Yazici
Hasan
H
D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D015994:Incidence; D008223:Lymphoma / Q000453:epidemiology* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha